ZYDUS LIFESCIENCES
|
The Current P/E Ratio of ZYDUS LIFESCIENCES is 21.51.
| Share Price | ₹1,074.3 | Jun 18,2026 |
| Market Cap | ₹108,096.1 Cr | |
| Earnings-TTM | ₹5,026.4 Cr | TTM-Consolidated Results |
| Price/Earnings | 21.51x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ZYDUS LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹108,096.1 Cr] as on Jun 18,2026
(/) Earnings [ ₹5,026.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 21.51x ]
Thus, for ZYDUS LIFESCIENCES , the investors are currently willing to pay 21.51 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ZYDUS LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ZYDUS LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of ZYDUS LIFESCIENCES
PE Ratio Performance Analysis for ZYDUS LIFESCIENCES
- ZYDUS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 20.08x.
- ZYDUS LIFESCIENCES 's operated at median p/e ratio of 21.16x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ZYDUS LIFESCIENCES 's p/e ratio peaked in Mar2024 at 26.2x.
- ZYDUS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2022 of 7.96x.
How does ZYDUS LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ZYDUS LIFESCIENCES | 5,026.40 | 21.51 | 108,096.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 37.84 | 437,639.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 69.96 | 179,647.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 70.33 | 150,366.0 |
| CIPLA LTD | 3,869.79 | 28.30 | 109,528.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 25.53 | 105,819.0 |
| MANKIND PHARMA LTD | 1,926.41 | 51.56 | 99,323.5 |
| LUPIN LTD | 5,355.47 | 19.87 | 106,421.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 23.71 | 83,029.9 |
| LAURUS LABS LTD | 889.85 | 83.17 | 74,008.8 |
| BIOCON LTD | 368.80 | 181.80 | 67,048.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ZYDUS LIFESCIENCES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 19.87x |
| Max industry PE | 181.80x |
| Median industry PE | 37.84x |
| Average industry PE | 55.78x |
You may also like the below Video Courses